Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcomeResearch in context
Background: There is a lack of information as to which molecular processes, present at diagnosis, favor tumour escape from standard-of-care treatments in cervical cancer (CC). RAIDs consortium (www.raids-fp7.eu), conducted a prospectively monitored trial, [BioRAIDs (NCT02428842)] with the objectives...
Similar Items
-
Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
by: Suzy Scholl, et al.
Published: (2020-07-01) -
Composition of the gut microbiota transcends genetic determinants of malaria infection severity and influences pregnancy outcomeResearch in context
by: Catherine D. Morffy Smith, et al.
Published: (2019-06-01) -
Autoantibodies in SLE: Specificities, Isotypes and Receptors
by: Barbara Dema, et al.
Published: (2016-01-01) -
The influence of feature selection methods on accuracy, stability and interpretability of molecular signatures.
by: Anne-Claire Haury, et al.
Published: (2011-01-01) -
Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer
by: Suzy M Scholl, et al.
Published: (2020-11-01)